
Please use this identifier to cite or link to this item:
http://dspace.bits-pilani.ac.in:8080/jspui/handle/123456789/18384
Title: | ULK1 as a therapeutic target in kidney diseases: Current perspective |
Authors: | Gaikwad, Anil Bhanudas |
Keywords: | Pharmacy Autophagy Kidney diseases ULK1 Therapeutic target Kidney homeostasis |
Issue Date: | Nov-2024 |
Publisher: | Taylor & Francis |
Abstract: | Globally, ~850 million people are affected by different kidney diseases. The pathogenesis of kidney diseases is intricate, where autophagy is crucial for maintaining kidney homeostasis. Iteliminates damaged organelles, thus reducing renal lesions and allowing tissue regeneration. Therefore, targeting various autophagy proteins, e.g. Unc–51–like autophagy-activating kinase 1 (ULK1), is emerging as potential therapeutic strategy against kidney disease. |
URI: | https://www.tandfonline.com/doi/full/10.1080/14728222.2024.2421762 http://dspace.bits-pilani.ac.in:8080/jspui/handle/123456789/18384 |
Appears in Collections: | Department of Pharmacy |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.